<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="drug\PMC7525249\results\search\zoonosis\results.xml">
  <result pre="10.1016/j.nmni.2020.100770100770 : Mini-Review Diagnostic approaches and potential therapeutic options for" exact="coronavirus disease 2019" post="KhanZ.12GhafoorD.23KhanA.4âˆ—âˆ—UaliyevaD.25KhanS.A.6BilalH.7KhanB.8KhanA.9SajjadW.10âˆ—[1)], [2)], [3)], [4)], [5)], [6)], [7)], [8)], [9)],"/>
  <result pre="as long as the COVID-19 resource centre remains active. Abstract" exact="Severe acute respiratory syndrome" post="coronavirus 2 (SARS-CoV-2) emerged in Wuhan city of China"/>
  <result pre="to its contagious nature, the virus spreads rapidly and causes" exact="coronavirus disease 2019" post="(COVID-19). The global tally of COVID-19 was 28 million"/>
  <result pre="respiratory syndrome coronavirus 2 (SARS-CoV-2), which caused an outbreak of" exact="coronavirus disease 2019" post="(COVID-19) in China, has brought about serious threats to"/>
  <result pre="(more cases reported in 2004). In 2012, the appearance of" exact="Middle East respiratory syndrome" post="coronavirus (MERS-CoV) in the Arabian Peninsula caused periodic epidemics"/>
  <result pre="random-access, point-of-care molecular devices for fast and accurate diagnosis of" exact="SARS-CoV-2 infection" post="[6]. As of 19 April 2020, the US Food"/>
  <result pre="[24,25] (Fig.3 ). Fig.Â 3 Scheme of investigated antiviral against" exact="coronavirus disease 2019," post="their potential targets and mechanism of action, Names of"/>
  <result pre="of COVID-19 up to 2 September 2020 (https://www.worldometers.info/coronavirus/). Fig.Â 2" exact="Coronavirus disease 2019" post="continent-wise distribution. Potential drugs against COVID-19 Currently, there is"/>
  <result pre="RNA polymerase, was initially developed as an antiviral drug against" exact="Ebola" post="virus and Marburg virus infections. Remdesivir has potential activity"/>
  <result pre="fevers [51,52], and to some extent it is effective against" exact="Ebola" post="virus [51,53,54]. Favipiravir is one of the possible drugs"/>
  <result pre="be reliably detected [87]. A negative result cannot sort out" exact="SARS-CoV-2 infection," post="especially in people who have recently been exposed to"/>
  <result pre="necessary to develop serological tests that can accurately assess previous" exact="SARS-CoV-2 infection" post="and immunity. In some countries/regions, immunoassays are already on"/>
  <result pre="Biological Inc./Beijing Institute of Biotechnology SARS-CoV-2 Phase 2 ChiCTR2000031781Phase 1ChiCTR2000030906" exact="Ebola" post="RNA LNP-encapsulated mRNA Moderna/NIAID SARS-CoV-2 Phase 2 NCT04405076Phase 1"/>
  <result pre="vaccine Clover Biopharmaceuticals Inc./GSK/Dynavax SARS-CoV-2 Phase 1 NCT04405908 HIV, REV" exact="Influenza" post="Protein Subunit Adjuvanted recombinant protein (RBD-Dimer) Anhui Zhifei Longcom"/>
  <result pre="Abbreviations: CCHF, Crimeanâ€&quot;Congo haemorrhagic fever virus; DENV, dengue virus; EBOV," exact="Ebola" post="virus; HIV, human immunodeficiency virus; HPV, human papillomavirus; Inf"/>
  <result pre="LASV, Lassa mammarenavirus; MARV, Marburg virus; MenB, meningitis B; MERS," exact="Middle East respiratory syndrome;" post="NIPV, Nipah virus; RABV, rabies virus; REV, reticuloendothelial virus;"/>
  <result pre="receptor for the emerging human coronavirus-EMCNature4957440201325125423486063 24MilletJ.K.WhittakerG.R.Host cell entry of" exact="Middle East respiratory syndrome" post="coronavirus after two-step, furin-mediated activation of the spike proteinProc"/>
  <result pre="the spike proteinProc Natl Acad Sci USA1112014152141521925288733 25KidoH.OkumuraY.YamadaH.LeT.Q.YanoM.Proteases essential for" exact="human influenza" post="virus entry into cells and their inhibitors as potential"/>
  <result pre="antiviral against hand, foot and mouth diseaseAntivir Res149201814314929175128 43SahraeiZ.ShabaniM.ShokouhiS.SaffaeiA.Aminoquinolines against" exact="coronavirus disease 2019" post="(COVID-19): chloroquine or hydroxychloroquineInt J Antimicrob Agents55202010594532194152 44MillionM.GautretP.ColsonP.RousselY.DubourgG.ChabriereE.Clinical efficacy"/>
  <result pre="Ser B, Phys Biol Sci932017449463 53BaiC.Q.MuJ.S.KargboD.SongY.B.NiuW.K.NieW.M.Clinical and virological characteristics of" exact="Ebola" post="virus disease patients treated with favipiravir (T-705)-Sierra Leone, 2014Clin"/>
  <result pre="(T-705)-Sierra Leone, 2014Clin Infect Dis6320161288129427553371 54CorrectionExperimental treatment with favipiravir for" exact="Ebola" post="virus disease (the JIKI trial): a historically controlled, single-arm"/>
  <result pre="Sci50Si-1202061161932293834 64RossignolJ.F.Nitazoxanide, a new drug candidate for the treatment of" exact="Middle East respiratory syndrome" post="coronavirusJÂ Infect Public Health9201622723027095301 65JasenoskyL.D.CadenaC.MireC.E.BorisevichV.HaridasV.RanjbarS.The FDA-approved oral drug nitazoxanide"/>
  <result pre="FDA-approved oral drug nitazoxanide amplifies host antiviral responses and inhibits" exact="Ebola" post="virusiScience1920191279129031402258 66CalyL.DruceJ.D.CattonM.G.JansD.A.WagstaffK.M.The FDA-approved drug ivermectin inhibits the replication of"/>
  <result pre="Microbiol5320153738374926354816 83MerckxJ.WaliR.SchillerI.CayaC.GoreG.C.ChartrandC.Diagnostic accuracy of novel and traditional rapid tests for" exact="influenza infection" post="compared with reverse transcriptase polymerase chain reaction: a systematic"/>
  <result pre="Clin Microbiol4220042884288915243033 85ChenY.ChanK.H.KangY.ChenH.LukH.K.PoonR.W.AÂ sensitive and specific antigen detection assay for" exact="Middle East respiratory syndrome" post="coronavirusEmerg Microb Infect42015e26 86SheridanC.Fast, portable tests come online to"/>
  <result pre="SARS-CoV-2: an observational cohort studyLancet Infect Dis20202056557432213337 90HosseinyM.KoorakiS.GholamrezanezhadA.ReddyS.MyersL.Radiology perspective of" exact="coronavirus disease 2019" post="(COVID-19): lessons from severe acute respiratory syndrome and middle"/>
 </snippets>
</snippetsTree>
